OneSource anticipates leading the generics market for semaglutide as multiple patents expire, expanding its capacity and ...

Canada should create a pharmacare system that offers free access to essential medicines to anyone with a health card and ...

Employees of the Canadian Mental Health Association painted two different pictures of Brandi Clarke on the second day of the ...

A Type 1 diabetic who recently moved to Nova Scotia said they paid hundreds of dollars out of pocket while trying to apply ...

The inquest into the death of Brandi Clarke got underway in Charlottetown on Tuesday with the testimony of the psychiatrist ...

What’s more, according to a new report by the Canadian Institute for Health Information, in 2025, health care spending in Canada is on track to grow nearly two percentage points faster than the ...

Embecta (Nasdaq:EMBC) today posted fourth-quarter financial results that proved mixed compared to the consensus forecast on ...

A Garvan-led clinical trial has found that using a common and inexpensive type 2 diabetes drug reduces insulin needs in type ...

After the federal budget revealed no additional funding for the federal pharmacare program, Newfoundland and Labrador NDP ...

Medicare will save approximately $12 billion, or 44%, on 15 high-cost medications as a result of the second round of the ...

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...